By Alison Fethke, Devin Cohen, Haley Bavasi and Charles O’Toole October 12, 2017, 12:05 PM EDT
Law360, New York (October 12, 2017, 12:05 PM EDT) -- Given the uptick in global awareness and enforcement of anti-bribery and corruption laws, most U.S.-based health care companies are attuned to the risks associated with legal infractions caused by their operations and conduct abroad. However, such ex-U.S. activities may also impact health care companies’ ability to conduct business within the U.S. For example, overseas conduct could trigger exclusion, debarment or suspension from federal procurement of health care programs, such as Medicare and Medicaid, even if the alleged wrongdoing (e.g., conduct relating to bribery or corruption) occurs...How Conduct Abroad Impacts Health Care Business In US
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login